By contrast, ADCY1 expression did not affect the prognosis of AML patients, suggesting the actions of group 2 adenylyl cyclases (ADCY2, ADCY4 and ADCY7) in AML differ from those in other cancers. Here, ADCY1 is linked to cancer.